Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients.
Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, Bouhnik Y, Serrero M, Armengol-Debeir L, Buisson A, Tran-Minh ML, Zallot C, Fumery M, Bouguen G, Abitbol V, Viennot S, Chanteloup E, Rajca S, Dib N, Parmentier AL, Peyrin-Biroulet L, Vuitton L; GETAID BioLAP Study Group.
Chapuis-Biron C, et al. Among authors: tran minh ml.
Aliment Pharmacol Ther. 2020 Apr;51(7):719-727. doi: 10.1111/apt.15665. Epub 2020 Feb 20.
Aliment Pharmacol Ther. 2020.
PMID: 32080886